Roche Media ٢٩ يناير ٢٠٢٦ Roche GLP-1 produces “robust” weight loss in late-stage obesity trial - European Pharmaceutical Review
Roche Media ٢٩ يناير ٢٠٢٦ Roche drops $100M Kiniksa fibrosis drug from phase 2 pipeline as part of quarterly clearout - Fierce Biotech
Roche Media ٢٧ يناير ٢٠٢٦ Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist | PharmExec - Pharmaceutical Executive
Roche Media ٢٧ يناير ٢٠٢٦ How Roche is Scaling Production After Obesity Breakthrough - Manufacturing Digital Magazine
Roche Media ٢٧ يناير ٢٠٢٦ Roche sees GLP1/GIP drug from Carmot produce 22.5% weight loss, readies phase 3 trial - Fierce Biotech
Roche Media ٢٧ يناير ٢٠٢٦ Roche announces positive phase II results for experimental obesity drug - wkzo.com
Roche Media ٢٧ يناير ٢٠٢٦ Is Roche Becoming a Contender in the Obesity Drug Market? - Healthcare Digital
Roche Media ٢٦ يناير ٢٠٢٦ Roche's Gazyva gets Health Canada approval for lupus nephritis - marketscreener.com
Roche Media ١١ يناير ٢٠٢٦ Roche: Making Preventative Healthcare Accessible to All - Healthcare Digital
Roche Media ٩ يناير ٢٠٢٦ Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com
Roche Media ٩ يناير ٢٠٢٦ Roche returns to Chinese biotech MediLink for another ADC pact - Endpoints News
Roche Media ٩ يناير ٢٠٢٦ Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech
Roche Media ٦ يناير ٢٠٢٦ In Structure licensing deal, Roche commits $100M to shore up GLP-1 position - Fierce Biotech
Roche Media ٦ يناير ٢٠٢٦ Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement - BioSpace
Roche Media ١ يناير ٢٠٢٦ AI-based Digital Pathology Market Intelligence Report, 2025-2035, Featuring Aiforia Technologies, Ibex Medical Analytics, Indica Labs, PathAI, Roche, Visiopharm and Many Other Key Players - ResearchAndMarkets.com - The AI Journal
Roche Media ٢٦ ديسمبر ٢٠٢٥ Emerson and Roche Collaborate on Digital Modality Library for Pharmaceutical Development - Automation World
Roche Media ٢٢ ديسمبر ٢٠٢٥ Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma - Medical Dialogues